ModelEdge

CollPlant Biotechnologies Ltd
CLGN
Filing Type20-F
Filing Date3/31/2020
Updated4/1/20, 1:57 AM

Filing

20-F
Earnings Release

Exhibits

20-FAnnual and Transition Report of Foreign Private Issuers
EX-2.1DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12
EX-4.24FORM OF CONVERTIBLE LOAN AGREEMENT BETWEEN THE COMPANY AND AMY SAGY
EX-4.25FORM OF CONVERTIBLE LOAN AGREEMENT BETWEEN THE COMPANY AND U.S. INVESTORS
EX-4.26FORM OF PRICE PROTECTION AGREEMENT BETWEEN THE COMPANY AND AMY SAGY
EX-4.27FORM OF PRICE PROTECTION AGREEMENT BETWEEN THE COMPANY AND U.S. INVESTORS
EX-4.28FORM OF REGISTRATION RIGHTS AGREEMENT
EX-4.29FORM OF WARRANT ISSUED BY THE COMPANY TO AMY SAGY AND U.S. INVESTORS PURSUANT TO THE CONVERTIBLE LOAN AGREEMENT
EX-4.30FORM OF SECURITIES PURCHASE AGREEMENT DATED AS OF FEBRUARY 13, 2020 BY AND BETWEEN THE COMPANY AND THE PURCHASERS NAMED THEREIN
EX-12.1CERTIFICATION
EX-12.2CERTIFICATION
EX-13.1CERTIFICATION
EX-13.2CERTIFICATION
EX-15.1CONSENT OF KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
EX-101.INSXBRL INSTANCE FILE